{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-09",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "68594-010",
      "generic_name": "Human papillomavirus type 16 L1 protein adsorbed",
      "labeler_name": "Boehringer Ingelheim RCV GmbH & Co KG",
      "active_ingredients": [
        {
          "name": "HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN",
          "strength": ".32 mg/mL"
        }
      ],
      "finished": false,
      "packaging": [
        {
          "package_ndc": "68594-010-99",
          "description": "45000 mL in 1 BOTTLE, GLASS (68594-010-99)",
          "marketing_start_date": "22-JAN-24"
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {},
      "marketing_category": "DRUG FOR FURTHER PROCESSING",
      "dosage_form": "LIQUID",
      "spl_id": "31a96ab4-0f81-5183-e063-6294a90afcc9",
      "product_type": "VACCINE",
      "marketing_start_date": "20240122",
      "product_id": "68594-010_31a96ab4-0f81-5183-e063-6294a90afcc9",
      "brand_name_base": null
    }
  ]
}